Filing metadata

Accession number
0001209191-22-053457
Form type
Form 4
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Oct 12, 2022
Reporting period
Oct 10, 2022
Description
Insider transaction

Explore SEC Filings Hub